Heron Therapeutics, Inc. Financial Ratios — HRTX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-138.43	-69.11	-91.56	-115.7	-107.73	- -	- -	-71.35	-52.91	-70.99	-140.53	-399.43	- -	- -	- -
Return on Assets (%)	-105.69	-61.92	-83.82	-100.08	-90.98	-168.65	-130.88	-51.35	-42	-52.47	-66.95	-65.4	-46.7	-5.96	-8.26
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	- -	- -	- -	- -	97.26	85.09	64.49	57.79	59.17	46.7	49.04	48.75	73.21	73.31
EBITDA Margin (%)	-1,684.67	- -	- -	- -	- -	-13,277.25	-627.38	-235.46	-142.94	-254.2	-248.77	-159.53	-84.79	-6.26	-0.14
Operating Margin (%)	-1,712.38	- -	- -	- -	- -	-13,363.17	-632.36	-237.42	-144.34	-257.41	-252.27	-162.21	-87.07	-7.99	-1.64
Incremental Operating Margin (%)	- -	1,976.63	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-1,770.12	- -	- -	- -	- -	-13,537.37	-641.87	-230.84	-140.27	-256.41	-255.58	-169.05	-87.02	-9.41	-13.04
Profit Margin (%)	-1,828.79	- -	- -	- -	- -	-13,537.37	-641.87	-230.84	-140.27	-256.41	-255.58	-169.05	-87.02	-9.41	-13.04
Net Income to Common Margin (%)	-1,828.79	- -	- -	- -	- -	-13,537.37	-641.87	-230.84	-140.27	-256.41	-255.58	-169.05	-87.02	-9.41	-13.04
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-138.43	-69.11	-91.56	-115.7	-107.73	- -	- -	-71.35	-52.91	-70.99	-140.53	-399.43	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	1	2	2	53	29	5	20	25	159	157	180	178	141
ST Debt	- -	- -	1	2	2	3	29	5	8	10	2	3	3	3	- -
LT Debt	- -	- -	- -	- -	- -	50	- -	- -	12	15	157	155	177	175	141
Total Debt/EBITDA	-0.01	-0.02	-0.02	-0.02	-0.02	-0.31	-0.15	-0.03	-0.09	-0.11	-0.74	-0.92	-1.67	-19.67	-627.85
Net Debt/EBITDA	1.64	2.24	1.32	0.96	0.76	-0.23	0.6	0.15	0.32	0.44	-0.27	-0.78	-1.35	-16.48	-499.96
Total Debt/EBIT	-0.01	-0.02	-0.02	-0.02	-0.02	-0.31	-0.15	-0.02	-0.09	-0.11	-0.73	-0.9	-1.62	-15.42	-55.41
Net Debt/EBIT	1.62	2.22	1.31	0.95	0.75	-0.23	0.6	0.15	0.31	0.43	-0.27	-0.77	-1.31	-12.92	-44.13
EBITDA to Interest Expense	-29.18	-39.06	-65.37	-83.41	-100.41	-63.74	-49.03	-68.27	-141.75	-118.52	-89.13	-69.43	-27.85	-1.5	-0.02
EBITDA-CapEx/Interest Expense	-30.55	-40.67	-67.4	-85.03	-101.54	-64.92	-49.68	-71.7	-146.61	-122.11	-90.39	-70.17	-28.25	-1.78	-0.06
EBIT to Interest Expense	-29.66	-39.39	-65.77	-84.06	-101.17	-64.16	-49.42	-68.84	-143.13	-120.02	-90.39	-70.6	-28.6	-1.91	-0.26
Interest Expense	- -	1	1	1	1	3	4	3	1	2	2	2	4	6	10
Common Equity/Total Assets	81.01	92.58	90.79	82.24	85.68	-31.49	55.97	80.09	78.75	66.89	25.37	5.41	-15.27	-14.43	5.19
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.03	6.16	202.5	1,140.46	- -	- -	981.22
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	157.93	- -	- -	2.89	5.58	66.26	90.49	121.21	121.24	90.75
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	74.09	- -	- -	2.39	4.12	51.38	61.68	79.35	74.94	54.96
Total Debt/Equity (%)	0.65	0.95	1.49	2.53	1.88	-248.98	21.87	1.24	4.9	10.41	205.61	1,160.31	-528.74	-528.25	981.22
Total Debt/Capital (%)	0.65	0.94	1.46	2.47	1.85	167.12	17.95	1.22	4.67	9.43	67.28	92.07	123.32	123.35	90.75
Total Debt/Total Assets (%)	0.53	0.88	1.35	2.08	1.61	78.41	12.24	0.99	3.86	6.96	52.17	62.75	80.73	76.25	54.96
Net Debt to Equity	-113.45	-102.31	-103.36	-112.71	-61.77	-185.86	-88.38	-7.36	-16.41	-41.47	75.47	986.74	-427.03	-442.55	781.35
Net Debt/Capital (%)	843.37	4,432.61	3,075.62	886.8	-161.58	216.47	-760.64	-7.95	-18.84	-62.89	39.95	86.02	124.02	125.88	88.65
EBITDA	-11	-24	-54	-74	-96	-170	-193	-182	-209	-225	-215	-172	-108	-9	- -
EBITDA-CapEx	-11	-25	-56	-75	-97	-173	-196	-192	-216	-232	-218	-174	-109	-11	-1
Operating Income (Loss)	-11	-24	-54	-75	-97	-171	-195	-184	-211	-228	-218	-175	-111	-12	-3

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.87	12.88	10.34	5.34	6.65	1.32	1.67	3.61	4.04	2.03	2.22	1.03	1.01	0.65	0.49
Current Ratio	4.94	13.02	10.43	5.41	6.83	1.6	2.21	4.86	4.95	3.07	3.58	2.49	2.37	2.29	2.48
Quick Ratio	4.87	12.88	10.34	5.34	6.65	1.37	2.08	4.31	4.46	2.44	2.72	1.66	1.76	1.51	1.42
CFO/Avg Current Liab	-2.94	-4.34	-7.31	-5.85	-4.71	-4.59	-2.4	-1.97	-1.32	-1.86	-2.34	-1.92	-0.73	-0.26	-0.29
Common Equity/Total Assets	81.01	92.58	90.79	82.24	85.68	-31.49	55.97	80.09	78.75	66.89	25.37	5.41	-15.27	-14.43	5.19
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.03	6.16	202.5	1,140.46	- -	- -	981.22
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	157.93	- -	- -	2.89	5.58	66.26	90.49	121.21	121.24	90.75
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	74.09	- -	- -	2.39	4.12	51.38	61.68	79.35	74.94	54.96
Total Debt/Equity (%)	0.65	0.95	1.49	2.53	1.88	-248.98	21.87	1.24	4.9	10.41	205.61	1,160.31	-528.74	-528.25	981.22
Total Debt/Capital (%)	0.65	0.94	1.46	2.47	1.85	167.12	17.95	1.22	4.67	9.43	67.28	92.07	123.32	123.35	90.75
Total Debt/Total Assets (%)	0.53	0.88	1.35	2.08	1.61	78.41	12.24	0.99	3.86	6.96	52.17	62.75	80.73	76.25	54.96
CFO/Total Liabilities	-209.07	-409.46	-582.99	-442.6	-397.9	-151.12	-165.07	-208.44	-114.35	-157.88	-89.14	-61.89	-22.92	-8.44	-11.42
CFO/CapEx	-15.05	-17.5	-24.19	-41.92	-72.31	-42.77	-66.71	-20.91	-17.41	-27.13	-67.29	-80.5	-38.05	-13.21	-87.04
Altman's Z-Score	-5.01	19.08	12.48	4.93	23.8	-16.59	0.15	10.09	8.33	3.23	-6.29	-10.54	-11.88	-9.94	-8.77

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	11.75	- -	- -	- -	- -	1.31	1.4	1.45	2.79	2.17	2.23	2.46	2.26	2.08	1.84
Days Sales Outstanding	31.08	- -	- -	- -	- -	279.67	260.01	250.94	130.69	168.27	163.48	148.39	161.16	175.84	198.48
Inventory Turnover	- -	- -	- -	- -	- -	0.01	0.59	1.12	1.93	1.08	1.02	1.07	1.35	0.81	0.57
Days Inventory Outstanding	- -	- -	- -	- -	- -	27,844.29	614.49	325.97	189.55	337.24	358.04	342.41	271.02	449.88	644.01
Accounts Payable Turnover	- -	- -	- -	- -	- -	0.96	0.7	3.13	4.72	28.74	23.32	16.37	14.25	6.41	7.82
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	379.91	522.18	116.43	77.35	12.7	15.65	22.3	25.61	56.95	46.68
Cash Conversion Cycle	- -	- -	- -	- -	- -	27,744.05	352.31	460.48	242.9	492.81	505.87	468.5	406.57	568.76	795.81
Inventory to Cash Days	- -	- -	- -	- -	- -	-27,564.61	-354.48	-75.03	-58.86	-168.96	-194.56	-194.02	-109.86	-274.04	-445.53
Inventories	- -	- -	- -	- -	- -	5	10	39	25	42	48	55	42	53	93
Raw Materials	- -	- -	- -	- -	- -	2	3	10	7	19	21	15	18	20	59
Work In Process	- -	- -	- -	- -	- -	1	4	21	13	7	21	21	15	27	27
Finished Goods	- -	- -	- -	- -	- -	3	3	8	6	16	6	19	10	6	7
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	46	166	212	294	964	516	1,169	2,028	2,122	1,933	931	298	255	233	245
- Cash & Cash Equivalents	18	54	72	73	75	13	145	32	72	105	91	15	29	26	29
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	1	2	2	53	29	5	20	25	159	157	180	178	141
Enterprise Value	28	113	141	223	835	517	1,026	1,700	1,751	1,749	933	371	355	351	340
Total Capital	16	52	70	65	120	32	160	375	424	261	237	171	146	144	155
Total Debt/Capital (%)	0.65	0.94	1.46	2.47	1.85	167.12	17.95	1.22	4.67	9.43	67.28	92.07	123.32	123.35	90.75
Total Debt / EV	- -	- -	0.01	0.01	- -	0.1	0.03	- -	0.01	0.01	0.17	0.43	0.51	0.51	0.41
EV/Sales	43.56	- -	- -	- -	- -	404.47	33.34	21.94	12	19.73	10.81	3.44	2.79	2.43	2.19
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	28	134	145	267	883	497	978	1,899	1,922	1,921	899	272	235	233	217
Diluted Enterprise Value	10	81	74	196	810	536	862	1,871	1,870	1,841	968	415	386	385	330
EV per Share	2.81	7.49	5.98	7.63	23.13	13.15	15.88	21.75	19.39	19.15	9.15	3.11	2.36	2.31	1.8
TTM Sales	1	- -	- -	- -	- -	1	31	77	146	89	86	108	127	144	155
TTM EBITDA	-11	-24	-54	-74	-96	-170	-193	-182	-209	-225	-215	-172	-108	-9	- -
TTM Operating Income	-11	-24	-54	-75	-97	-171	-195	-184	-211	-228	-218	-175	-111	-12	-3
TTM Cash Flow to Firm	-7	-16	-40	-59	-78	-131	-166	-189	-123	-183	-201	-144	-55	-16	-18
TTM Free Cash Flow to Firm	-7	-15	-38	-58	-76	-128	-164	-180	-116	-176	-198	-143	-53	-15	-18

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-3.84	-8.38	-3.72	-4.54	-11.41	-3.79	-5.83	-10.4	-16.37	-10.79	-4.49	-1.88	-4.1	-11.2	-7.95
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	28	113	141	223	835	517	1,026	1,700	1,751	1,749	933	371	355	351	340
Low Price	2	3.4	5.6	6.51	7.09	12.3	12.21	17.85	15.68	9.6	8.22	2.19	0.5	1.04	1
EV/Sales	43.56	- -	- -	- -	- -	404.47	33.34	21.94	12	19.73	10.81	3.44	2.79	2.43	2.19
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-2.96	-5.4	-2.77	-3.64	-7.69	-4.02	-4.13	-12.23	-8.64	-6.81	-6.24	-2.76	-2.12	-26.88	-13.99
Price/Earnings High	-6.01	-8.17	-5.2	-5.5	-14.32	-6.15	-5.35	-17.56	-11.46	-9.89	-9.66	-6.23	-4.26	-44.12	-22.12
Price/Earnings Low	-1.02	-1.78	-1.64	-2.26	-2.4	-2.69	-3.34	-7.31	-6.26	-3.83	-3.67	-1.31	-0.62	-11.68	-8.25
Price/Book Value	2.92	3.21	3.08	4.66	8.16	-24.26	8.92	5.48	5.25	8.17	12.01	21.95	-7.52	-6.92	18.43
Price/Book Value Average	3.69	3.01	3.24	4.85	6.94	-34.02	7.43	6.31	4.84	6.58	18.38	40.44	-7.52	-10.82	24.02
Price/Book Value High	7.49	4.55	6.09	7.33	12.92	-52.04	9.63	9.06	6.42	9.56	28.46	91.31	-15.08	-17.77	37.99
Price/Book Value Low	1.27	0.99	1.91	3.02	2.17	-22.78	6.02	3.77	3.51	3.71	10.82	19.23	-2.21	-4.7	14.18
Price/Tangible Book Value	2.92	3.21	3.08	4.66	8.16	-24.26	8.92	5.48	5.25	8.17	12.01	21.95	-7.52	-6.92	18.43
Price/Tangible Book Value Average	3.69	3.01	3.24	4.85	6.94	-34.02	7.43	6.31	4.84	6.58	18.38	40.44	-7.52	-10.82	24.02
Price/Tangible Book Value High	7.49	4.55	6.09	7.33	12.92	-52.04	9.63	9.06	6.42	9.56	28.46	91.31	-15.08	-17.77	37.99
Price/Tangible Book Value Low	1.27	0.99	1.91	3.02	2.17	-22.78	6.02	3.77	3.51	3.71	10.82	19.23	-2.21	-4.7	14.18
Price/Sales	42.82	- -	- -	- -	- -	388.44	31.79	24.51	13.17	21.68	10.41	2.53	1.85	1.62	1.4
Price/Sales Average	54.1	- -	- -	- -	- -	544.67	26.49	28.23	12.11	17.45	15.94	4.66	1.85	2.53	1.82
Price/Sales High	109.83	- -	- -	- -	- -	833.22	34.34	40.53	16.08	25.36	24.68	10.53	3.71	4.15	2.88
Price/Sales Low	18.62	- -	- -	- -	- -	364.72	21.45	16.86	8.78	9.83	9.38	2.22	0.54	1.1	1.08
Price/Cash Flow	-3.58	-7.9	-3.57	-4.43	-11.25	-3.7	-5.74	-9.9	-15.43	-10.4	-4.42	-1.85	-3.99	-10.35	-7.85
Price/Cash Flow Average	-4.53	-7.41	-3.75	-4.62	-9.56	-5.19	-4.79	-11.4	-14.19	-8.37	-6.77	-3.42	-3.99	-16.2	-10.24
Price/Cash Flow High	-9.19	-11.21	-7.06	-6.97	-17.8	-7.95	-6.2	-16.37	-18.84	-12.16	-10.48	-7.72	-8.01	-26.59	-16.19
Price/Cash Flow Low	-1.56	-2.44	-2.22	-2.87	-2.99	-3.48	-3.88	-6.81	-10.29	-4.72	-3.98	-1.62	-1.17	-7.04	-6.04
Price/Free Cash Flow Average	-4.85	-7.86	-3.92	-4.73	-9.69	-5.32	-4.86	-11.97	-15.06	-8.69	-6.87	-3.46	-4.1	-17.53	-10.36
Price/Free Cash Flow High	-9.84	-11.89	-7.36	-7.14	-18.05	-8.14	-6.3	-17.19	-19.99	-12.63	-10.64	-7.81	-8.23	-28.77	-16.38
Price/Free Cash Flow Low	-1.67	-2.59	-2.32	-2.94	-3.03	-3.56	-3.93	-7.15	-10.92	-4.9	-4.04	-1.65	-1.21	-7.61	-6.11
EV/Sales Average	62.34	- -	- -	- -	- -	596.09	27.91	29.8	13.02	16.65	17.31	6.42	3.2	3.58	2.79
EV/Sales High	155.04	- -	- -	- -	- -	895.52	37.29	42.94	17.4	24.6	26.36	12.83	5.22	5.2	3.99
EV/Sales Low	3.3	- -	- -	- -	- -	409.35	21.88	17.66	9.34	8.98	10.52	3.74	1.78	2.15	1.95
EV/EBITDA Average	-3.7	-4.35	-2.81	-3.18	-7.76	-4.49	-4.45	-12.65	-9.11	-6.55	-6.96	-4.02	-3.77	-57.13	-1,928.94
EV/EBITDA High	-9.2	-7.73	-6.44	-5.29	-15.1	-6.74	-5.94	-18.23	-12.17	-9.68	-10.6	-8.04	-6.16	-82.98	-2,757.69
EV/EBITDA Low	-0.2	0.07	-1.12	-1.61	-1.9	-3.08	-3.49	-7.5	-6.54	-3.53	-4.23	-2.35	-2.1	-34.33	-1,345.25
EV/EBIT Average	-3.64	-4.32	-2.79	-3.15	-7.7	-4.46	-4.41	-12.55	-9.02	-6.47	-6.86	-3.96	-3.67	-44.78	-170.25
EV/EBIT High	-9.05	-7.67	-6.4	-5.25	-14.99	-6.7	-5.9	-18.08	-12.05	-9.56	-10.45	-7.91	-6	-65.04	-243.39
EV/EBIT Low	-0.19	0.07	-1.12	-1.6	-1.89	-3.06	-3.46	-7.44	-6.47	-3.49	-4.17	-2.31	-2.04	-26.91	-118.73
Last Price	4.6	11	9	10.06	26.7	13.1	18.1	25.94	23.5	21.16	9.13	2.5	1.7	1.53	1.3
High Price	11.8	15.6	17.8	15.82	42.25	28.1	19.55	42.9	28.7	24.76	21.64	10.4	3.41	3.93	2.68
Enterprise Value Average	40	103	152	235	746	762	859	2,309	1,901	1,475	1,495	691	406	516	432
Enterprise Value High	100	183	348	391	1,453	1,145	1,147	3,326	2,540	2,180	2,276	1,381	663	750	618
Enterprise Value Low	2	-2	61	119	183	524	673	1,368	1,364	796	908	403	226	310	301

Shares Outstanding	10	15	24	29	36	39	65	78	90	91	102	119	150	152	188
Diluted Weighted Avg Shares	6	12	16	27	33	38	54	73	82	91	98	109	138	152	167
Basic Weighted Avg Shares	6	12	16	27	33	38	54	73	82	91	98	109	138	152	167
Revenue per Share	0.11	- -	- -	- -	- -	0.03	0.57	1.06	1.78	0.98	0.88	0.99	0.92	0.95	0.93
EBITDA per Share	-1.81	-1.93	-3.35	-2.78	-2.91	-4.48	-3.57	-2.49	-2.55	-2.48	-2.18	-1.58	-0.78	-0.06	- -
Operating Income per Share	-1.84	-1.95	-3.37	-2.81	-2.93	-4.51	-3.6	-2.51	-2.58	-2.51	-2.21	-1.6	-0.8	-0.08	-0.02
Basic EPS, GAAP	-1.96	-1.91	-3.42	-2.87	-2.95	-4.57	-3.65	-2.44	-2.5	-2.5	-2.24	-1.67	-0.8	-0.09	-0.12
Basic EPS from Cont Ops	-1.9	-2	-3.42	-2.87	-2.95	-4.57	-3.65	-2.44	-2.5	-2.5	-2.24	-1.67	-0.8	-0.09	-0.12
Diluted EPS, GAAP	-1.96	-1.91	-3.42	-2.87	-2.95	-4.57	-3.65	-2.44	-2.5	-2.5	-2.24	-1.67	-0.8	-0.09	-0.12
Diluted EPS from Cont Ops	-1.9	-2	-3.42	-2.87	-2.95	-4.57	-3.65	-2.44	-2.5	-2.5	-2.24	-1.67	-0.8	-0.09	-0.12
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.28	-1.39	-2.52	-2.27	-2.37	-3.54	-3.15	-2.62	-1.52	-2.04	-2.07	-1.35	-0.43	-0.15	-0.17
Free Cash Flow per Basic Share	-1.37	-1.47	-2.63	-2.32	-2.41	-3.62	-3.2	-2.75	-1.61	-2.11	-2.1	-1.36	-0.44	-0.16	-0.17
Cash & Equivalents per Share	1.8	3.54	3.07	2.49	3.63	1.3	2.67	4.25	4.33	2.28	1.54	0.71	0.54	0.39	0.25
Book Value per Share	1.57	3.43	2.92	2.16	3.27	-0.54	2.03	4.74	4.47	2.59	0.76	0.11	-0.23	-0.22	0.07
Tangible Book Value per Share	1.57	3.43	2.92	2.16	3.27	-0.54	2.03	4.74	4.47	2.59	0.76	0.11	-0.23	-0.22	0.07

Heron Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)